CASI Pharmaceuticals, Inc. (CASIF) Stock Overview
Explore CASI Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
CASI Pharmaceuticals, Inc. (CASIF)
Key Financials
Key Financials
Market Cap
2.6M
P/E Ratio
-0.05
EPS (TTM)
$-2.68
ROE
2.04%
CASIF Stock Analysis & Investment Overview (PNK)
Our AI-powered analysis of CASI Pharmaceuticals, Inc. (PNK: CASIF) gives investors deep insight into how the stock performs on the PNK exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, CASI Pharmaceuticals, Inc.'s PNK-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CASIF on the PNK shows an RSI of 47.14, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.08 for the PNK listing.
Key metrics behind CASI Pharmaceuticals, Inc.'s PNK-traded stock include a P/E ratio of -0.05 and a market capitalization of 2.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CASIF on the PNK.